Singular Genomics Stock Forecast - Market Facilitation Index
| OMIC Stock | USD 20.00 0.90 4.31% |
Singular Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Singular Genomics stock prices and determine the direction of Singular Genomics Systems's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Singular Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Singular |
| Check Singular Genomics Volatility | Backtest Singular Genomics | Information Ratio |
Singular Genomics Trading Date Momentum
| On December 10 2024 Singular Genomics Systems was traded for 20.00 at the closing time. The top price for the day was 20.82 and the lowest listed price was 20.00 . The trading volume for the day was 23.4 K. The trading history from December 10, 2024 did not result in any price rise and fall. The trading price change against the current closing price is 2.75% . |
Market Facilitation Index was developed by Dr. Bill Williams. This indicator can help to determine either strong or week signal that can follow the current trend line by looking at how Market Facilitation index correlates with trading volume over time.
| Compare Singular Genomics to competition |
Other Forecasting Options for Singular Genomics
For every potential investor in Singular, whether a beginner or expert, Singular Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Singular Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Singular. Basic forecasting techniques help filter out the noise by identifying Singular Genomics' price trends.Singular Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Singular Genomics stock to make a market-neutral strategy. Peer analysis of Singular Genomics could also be used in its relative valuation, which is a method of valuing Singular Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Singular Genomics Systems Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Singular Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Singular Genomics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Singular Genomics Market Strength Events
Market strength indicators help investors to evaluate how Singular Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Singular Genomics shares will generate the highest return on investment. By undertsting and applying Singular Genomics stock market strength indicators, traders can identify Singular Genomics Systems entry and exit signals to maximize returns.
| Accumulation Distribution | 921.02 | |||
| Daily Balance Of Power | (1.10) | |||
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 20.41 | |||
| Day Typical Price | 20.27 | |||
| Price Action Indicator | (0.86) | |||
| Period Momentum Indicator | (0.90) |
Singular Genomics Risk Indicators
The analysis of Singular Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Singular Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting singular stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.72 | |||
| Semi Deviation | 2.57 | |||
| Standard Deviation | 17.3 | |||
| Variance | 299.45 | |||
| Downside Variance | 13.67 | |||
| Semi Variance | 6.62 | |||
| Expected Short fall | (9.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Singular Genomics Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Singular Genomics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Singular Genomics Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Singular Genomics Systems Stock:Check out Historical Fundamental Analysis of Singular Genomics to cross-verify your projections. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Singular Genomics. If investors know Singular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Singular Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.68) | Revenue Per Share 1.107 | Quarterly Revenue Growth 0.459 | Return On Assets (0.24) | Return On Equity (0.52) |
The market value of Singular Genomics Systems is measured differently than its book value, which is the value of Singular that is recorded on the company's balance sheet. Investors also form their own opinion of Singular Genomics' value that differs from its market value or its book value, called intrinsic value, which is Singular Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Singular Genomics' market value can be influenced by many factors that don't directly affect Singular Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Singular Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Singular Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Singular Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.